Surgical pleth index-guided remifentanil administration during functional endoscopic sinus surgery under sevoflurane anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17010381

Enrollment

Unknown

Registered

2017-01-11

Start date

2017-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional endoscopic sinus surgery

Interventions

SPI Group:Surgical pleth index-guided remifentanil analgesia

Con Group:conventional remifentanil analgesia

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists physical class I or II, scheduled for functional endoscopic sinus surgery, were enrolled in this study.

Exclusion criteria

Exclusion criteria: Exclusion criteria were a history of significant cardiovascular (e.g. arrhythmia), renal, hepatic, endocrinologic, neuromuscular, or neurological disease, abuse of alcohol or illicit drugs, were on medication or drugs that may affect autonomous regulation (e.g. ß-blocker, clonidine).

Design outcomes

Primary

Measure	Time frame
intraoperative remifentanil consumption;awaken time;extubation time;somatic movement;	—

Secondary

Measure	Time frame
intraoperative hemodynamic events;BIS;postoperative pain;postoperative nausea and vomiting;intraoperative awareness;	—

Countries

China

Contacts

Public ContactBoxiang Du

The Second Affiliated Hospital of Nantong University

boxiang_du@aliyun.com+86 15262839991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026